Aug. 11, 2024
Roche is reportedly considering the sale of Flatiron Health, a cancer data specialist that it acquired for $1.9 billion in …
Aug. 9, 2024
Tampa General Hospital (TGH) has introduced Apella, an artificial intelligence (AI) platform designed to enhance safety and efficiency in its …
Aug. 9, 2024
A recent study from the University of Oxford reveals that proteins carried in the blood can offer significant insights into …
Aug. 9, 2024
Insilico Medicine, a clinical-stage biotechnology company specializing in generative AI-driven drug discovery, has announced that its novel compound, ISM6331, has …
Aug. 8, 2024
Recursion Pharmaceuticals, a biotech firm leveraging artificial intelligence (AI) for drug discovery, has announced its acquisition of Exscientia, a smaller …
Aug. 8, 2024
Unilabs and C2N Diagnostics have announced a collaboration to launch the first-ever blood test for Alzheimer's disease detection in 75 …
Aug. 8, 2024
Cell Microsystems has expanded its contract research lab services to include cell line and custom organoid development, utilizing its proprietary …
Aug. 8, 2024
Researchers at Harvard's Wyss Institute for Biologically Inspired Engineering and the John A. Paulson School of Engineering and Applied Science …
Aug. 6, 2024
The NHS is under unprecedented strain, with wait and referral times reaching record highs and a £749 million overspend leading …
Aug. 6, 2024
Riverlane, a company based in Cambridge, UK, has raised $75 million in a Series C funding round to advance its …
Aug. 6, 2024
Researchers at UCLA Health's Jonsson Comprehensive Cancer Center have launched a pioneering clinical trial to evaluate the safety and efficacy …
Aug. 5, 2024
Lantern Pharma has announced positive preliminary results from the ongoing Phase 2 HARMONIC clinical trial, targeting never smokers with advanced …
